Relmada Therapeutics | 8-K:重大事件
Relmada Therapeutics | 4:持股变动声明-高管 TRAVERSA SERGIO
Relmada Therapeutics | 4:持股变动声明-高管 Shenouda Maged
Relmada Therapeutics | 4:持股变动声明-董事 Kelly Paul Edward
Relmada Therapeutics | 4:持股变动声明-董事 GLASSPOOL JOHN
Relmada Therapeutics | 4:持股变动声明-董事 Fedeli Fabiana
Relmada Therapeutics | 4:持股变动声明-高管 Ence Chuck
Relmada Therapeutics | 4:持股变动声明-董事 CASAMENTO CHARLES J
Relmada Therapeutics | 10-Q:季度报表
Relmada Therapeutics | DEFA14A:其他
Relmada Therapeutics | DEF 14A:股东委托书决议
Relmada Therapeutics | 8-K:Relmada Therapeutics提供公司最新情况并报告2023年第四季度和全年财务业绩
Relmada Therapeutics | 10-K:年度报表
Relmada Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%)等
Relmada Therapeutics | 144:拟议出售证券
Relmada Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.79%),Deep Track Biotechnology Master Fund, Ltd.(6.79%)等
Relmada Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
Relmada Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(4.35%)
Relmada Therapeutics | 4:持股变动声明-高管 TRAVERSA SERGIO
Relmada Therapeutics | 4:持股变动声明-高管 Shenouda Maged
暂无数据